xCures raises $46 million to organize patient data

Key takeaway

• xCures, a healthcare AI startup that organizes fragmented patient medical records for hospitals and health networks, has raised $46 million（約74億円） in Series B funding at a $127 million（約200億円） valuation.

• The company's technology converts messy, scattered patient data into structured clinical insights that support surgical planning, diagnosis, and administrative decisions across the U.S. healthcare system.

3 Key Points

FAQ

What does xCures' product actually do?

xCures integrates patient records from thousands of incompatible sources—hospitals, labs, imaging centers, electronic medical records—and transforms unstructured documents (including scanned records, pictures, and narrative notes full of human entry errors) into structured, decision-ready clinical information. The company calls this capability its 'Clinical Clarity Engine.'

Who is using xCures?

The company has 25 enterprise customers, including lab diagnostic companies such as Exact Sciences, Caris Life Sciences, and Novocure. Large hospital networks use it for operating-room scheduling and screening for patient comorbidities; telehealth providers without robust electronic health record systems use it; and Medicare Advantage plans use it for population risk stratification and prior authorizations.

How fast is the company growing?

xCures grew annualized recurring revenue from roughly $3 million（約4.8億円） to $10 million（約16億円） in 2025, and is on track to break $20 million（約32億円） in 2026. The company achieved cash-flow breakeven last year but has intentionally entered a capital-burn phase to build its team for its 2027 business pipeline.